Literature DB >> 17729388

Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?

Giovanni Tarantino1.   

Abstract

The highly increasing prevalence of obesity and type 2 diabetes mellitus in the general population makes nonalcoholic fatty liver disease the most common diagnosis in every-day practices. Lifestyle changes (mainly exercise withdrawal and weight gain) have probably heightened the prevalence of nonalcoholic fatty liver disease. Mortality in patients with Nonalcoholic Fatty Liver Disease is significantly higher when compared with that of the same age-gender general population. Hepatologists claim to bear a new burden, being Nonalcoholic Fatty Liver Disease strongly linked to systemic diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17729388      PMCID: PMC4611188          DOI: 10.3748/wjg.v13.i35.4669

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups.

Authors:  Kyoko Nomura; Eiji Yano; Toshiaki Shinozaki; Kazumi Tagawa
Journal:  J Occup Health       Date:  2004-11       Impact factor: 2.708

2.  Prevalence of fatty liver in non-obese Japanese children with atopic dermatitis.

Authors:  Hajime Kimata
Journal:  Indian Pediatr       Date:  2005-06       Impact factor: 1.411

3.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.

Authors:  Camilo Boza; Arnoldo Riquelme; Luis Ibañez; Ignacio Duarte; Enrique Norero; Paola Viviani; Alejandro Soza; Jose Ignacio Fernandez; Alejandro Raddatz; Sergio Guzman; Marco Arrese
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

5.  Non-alcoholic fatty liver disease in Malaysia: a demographic, anthropometric, metabolic and histological study.

Authors:  Abdul Malik; Phaik-Leng Cheah; Ida Normiha Hilmi; Siew Pheng Chan; Khean-Lee Goh
Journal:  J Dig Dis       Date:  2007-02       Impact factor: 2.325

6.  Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.

Authors:  Yusuf Yilmaz; Enver Dolar; Engin Ulukaya; Semra Akgoz; Murat Keskin; Murat Kiyici; Sibel Aker; Arzu Yilmaztepe; Selim Gurel; Macit Gulten; Selim-Giray Nak
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

7.  Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study.

Authors:  Henrik Toft Sørensen; Lene Mellemkjaer; Peter Jepsen; Ane Marie Thulstrup; John Baron; Jørgen H Olsen; Hendrik Vilstrup
Journal:  J Clin Gastroenterol       Date:  2003-04       Impact factor: 3.062

8.  Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.

Authors:  Tracy L Setji; Nicole D Holland; Linda L Sanders; Kathy C Pereira; Anna Mae Diehl; Ann J Brown
Journal:  J Clin Endocrinol Metab       Date:  2006-02-21       Impact factor: 5.958

9.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

10.  Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.

Authors:  Gary A Abrams; Sachin S Kunde; Audrey J Lazenby; Ronald H Clements
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

View more
  23 in total

Review 1.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 2.  JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.

Authors:  Giovanni Tarantino; Armando Caputi
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

3.  Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Francesco Scopacasa; Annamaria Colao; Domenico Capone; Marianna Tarantino; Ernesto Grimaldi; Silvia Savastano
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

4.  Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.

Authors:  Carmen Fierbinteanu-Braticevici; Ion Dina; Ana Petrisor; Laura Tribus; Lucian Negreanu; Catalin Carstoiu
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

Review 5.  Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance.

Authors:  Giovanni Tarantino; Silvia Savastano; Annamaria Colao
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

6.  Antioxidant activity of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetes in rats.

Authors:  Wen-Peng Yuan; Bing Liu; Chang-Heng Liu; Xiao-Jun Wang; Mian-Song Zhang; Xiu-Mei Meng; Xue-Kui Xia
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

7.  Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock.

Authors:  Basilia Zingarelli; Ranjit Chima; Michael O'Connor; Giovanna Piraino; Alvin Denenberg; Paul W Hake
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-19       Impact factor: 4.052

8.  Apoptosis induced by a low-carbohydrate and high-protein diet in rat livers.

Authors:  Maria Emília L Monteiro; Analucia R Xavier; Felipe L Oliveira; Porphirio Js Filho; Vilma B Azeredo
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

Review 9.  Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.

Authors:  Monika Ciupińska-Kajor; Marek Hartleb; Maciej Kajor; Michał Kukla; Mariusz Wyleżoł; Dariusz Lange; Lukasz Liszka
Journal:  Hepatol Int       Date:  2011-11-29       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.